BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31889488)

  • 1. Combining Antimicrobial Peptides with Nanotechnology: An Emerging Field in Theranostics.
    Mohid SA; Bhunia A
    Curr Protein Pept Sci; 2020; 21(4):413-428. PubMed ID: 31889488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria.
    Almaaytah A; Mohammed GK; Abualhaijaa A; Al-Balas Q
    Drug Des Devel Ther; 2017; 11():3159-3170. PubMed ID: 29138537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic antimicrobial peptides: Characteristics, design, and potential as alternative molecules to overcome microbial resistance.
    Lima PG; Oliveira JTA; Amaral JL; Freitas CDT; Souza PFN
    Life Sci; 2021 Aug; 278():119647. PubMed ID: 34043990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rediscovery of antimicrobial peptides as therapeutic agents.
    Ryu M; Park J; Yeom JH; Joo M; Lee K
    J Microbiol; 2021 Feb; 59(2):113-123. PubMed ID: 33527313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of tungsten disulfide quantum dot-conjugated antimicrobial peptides in bio-imaging and antimicrobial therapy.
    Mohid SA; Ghorai A; Ilyas H; Mroue KH; Narayanan G; Sarkar A; Ray SK; Biswas K; Bera AK; Malmsten M; Midya A; Bhunia A
    Colloids Surf B Biointerfaces; 2019 Apr; 176():360-370. PubMed ID: 30658284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnologies to Improve the Pharmacological Profile of Therapeutic Peptides.
    Casciaro B; Mangoni ML
    Curr Protein Pept Sci; 2020; 21(4):332-333. PubMed ID: 32400322
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells.
    Shagaghi N; Clayton AHA; Aguilar MI; Lee TH; Palombo EA; Bhave M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33207639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-peptide conjugates for bacterial detection and neutralization: Potential applications in diagnostics and therapy.
    Gonçalves S; Martins IC; Santos NC
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Nov; 14(6):e1819. PubMed ID: 36416027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles and their antimicrobial properties against pathogens including bacteria, fungi, parasites and viruses.
    Khezerlou A; Alizadeh-Sani M; Azizi-Lalabadi M; Ehsani A
    Microb Pathog; 2018 Oct; 123():505-526. PubMed ID: 30092260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dealing with MDR bacteria and biofilm in the post-antibiotic era: Application of antimicrobial peptides-based nano-formulation.
    Song X; Liu P; Liu X; Wang Y; Wei H; Zhang J; Yu L; Yan X; He Z
    Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112318. PubMed ID: 34474869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal Binding Antimicrobial Peptides in Nanoparticle Bio-functionalization: New Heights in Drug Delivery and Therapy.
    Moulahoum H; Ghorbani Zamani F; Timur S; Zihnioglu F
    Probiotics Antimicrob Proteins; 2020 Mar; 12(1):48-63. PubMed ID: 31001788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemically modified and conjugated antimicrobial peptides against superbugs.
    Li W; Separovic F; O'Brien-Simpson NM; Wade JD
    Chem Soc Rev; 2021 Apr; 50(8):4932-4973. PubMed ID: 33710195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-bacterial activity of inorganic nanomaterials and their antimicrobial peptide conjugates against resistant and non-resistant pathogens.
    Pardhi DM; Şen Karaman D; Timonen J; Wu W; Zhang Q; Satija S; Mehta M; Charbe N; McCarron PA; Tambuwala MM; Bakshi HA; Negi P; Aljabali AA; Dua K; Chellappan DK; Behera A; Pathak K; Watharkar RB; Rautio J; Rosenholm JM
    Int J Pharm; 2020 Aug; 586():119531. PubMed ID: 32540348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of LFchimera and antibiotic against planktonic and biofilm form of Aggregatibacter actinomycetemcomitans.
    Lachica MRCT; Anutrakunchai C; Prajaneh S; Nazmi K; Bolscher JGM; Taweechaisupapong S
    PLoS One; 2019; 14(7):e0217205. PubMed ID: 31329599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Engineering and Discovery of Novel α-Helical and β-Boomerang Antimicrobial Peptides against Drug Resistant Bacteria.
    Bhattacharjya S; Straus SK
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32796755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The advanced role of carbon quantum dots in nanomedical applications.
    Devi P; Saini S; Kim KH
    Biosens Bioelectron; 2019 Sep; 141():111158. PubMed ID: 31323605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Applications of Aggregation Induced Emission Probes for Antimicrobial Peptide Studies.
    Luu T; Li W; O'Brien-Simpson NM; Hong Y
    Chem Asian J; 2021 May; 16(9):1027-1040. PubMed ID: 33723926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic molecular evolution of host cell-compatible, antimicrobial peptides effective against drug-resistant, biofilm-forming bacteria.
    Starr CG; Ghimire J; Guha S; Hoffmann JP; Wang Y; Sun L; Landreneau BN; Kolansky ZD; Kilanowski-Doroh IM; Sammarco MC; Morici LA; Wimley WC
    Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8437-8448. PubMed ID: 32241895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria.
    Chung PY; Khanum R
    J Microbiol Immunol Infect; 2017 Aug; 50(4):405-410. PubMed ID: 28690026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.